PARAGON-HF - Why We Do Randomized, Controlled Clinical Trials
N Engl J Med
.
2019 Oct 24;381(17):1675-1676.
doi: 10.1056/NEJMe1912402.
Authors
Christopher M O'Connor
1
,
Christopher deFilippi
1
Affiliation
1
From Inova Heart and Vascular Institute, Falls Church, VA.
PMID:
31644849
DOI:
10.1056/NEJMe1912402
No abstract available
Publication types
Editorial
Comment
MeSH terms
Angiotensins
Heart Failure*
Humans
Neprilysin*
Stroke Volume
Substances
Angiotensins
Neprilysin